The company issued Senior Notes on March 7, 2024: ¥7,100,000,000 due 2029 at 1.009%, ¥23,100,000,000 due 2031 at 1.415%, and ¥16,700,000,000 due 2034 at 1.670%.

1. 01

   The company issued Senior Notes on March 7, 2024: ¥7,100,000,000 due 2029 at 1.009%, ¥23,100,000,000 due 2031 at 1.415%, and ¥16,700,000,000 due 2034 at 1.670%.

2. 02

   It issued on the same day ¥11,200,000,000 due 2039 at 1.953%, ¥15,500,000,000 due 2044 at 2.195%, ¥23,500,000,000 due 2054 at 2.390%, and ¥15,200,000,000 due 2059 at 2.448% in Senior Notes.

3. 03

   MetLife said it issued the Senior Notes under the Senior Indenture dated November 9, 2001 with The Bank of New York Mellon Trust Company, N.A. as trustee, with 7 supplemental indentures, from the Thirty-Ninth through the Forty-Fifth, dated March 7, 2024, applying to the individual series of notes.

4. 04

   The company offered and sold the Senior Notes under its Form S-3 shelf registration statement filed on November 17, 2022 and a prospectus supplement dated March 1, 2024. On March 1, 2024, it entered into an underwriting agreement and a pricing agreement with 4 representative underwriters, including Mizuho Securities USA LLC.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.